Micro Emerging Active

VR Adviser compra Spyre Therapeutics

New narrative with limited coverage — still forming.

Puntuación
0,2
Velocidad
▲ 0,0
Artículos
2
Fuentes
1

Top Movers

TickerSectorCambio
SYRE
Healthcare+61,1%

Sentiment Timeline

Rendimiento Sectorial

Stock Performance

Event Timeline

Abr 08, 2026
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 … Neutral
Mar 19, 2026
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools Neutral

Artículos Relacionados

Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools

Nasdaq · Mar 19, 2026

Cronología

Visto por primera vezMar 19, 2026
Última actualizaciónMar 19, 2026